Skip to main content

Teledermatology Market Size [2021-2028], Share, Growth Factors, Industry Trends, Competitive Analysis, Revenue & Forecast

Written by Customer Service on . Posted in Mergers And Acquisitions.

Key Prominent Players Covered in the Teledermatology Market are, 3Gen (U.S.), Ksyos (Netherlands), MetaOptima (Canada), 3Derm(U.S.), VigNet Inc. (U.S.), Mple(Canada) , MDLIVE Inc.(U.S.), CureSkin(India), Ping an Good Doctor (China), FirstDerm (U.S.)

Pune, India, Nov. 25, 2021 (GLOBE NEWSWIRE) — The global “teledermatology market” size is projected to grow from USD 14.32 billion in 2021 to USD 68.54 billion by 2028, exhibiting a CAGR of 25.1% during the forecast period. Increasing cases of skin disorders are likely to boost the product’s adoption. Fortune Business Insights™ provides this information in its report titled “Teledermatology Market, 2021-2028”. The report also reveals that the market size was USD 10.80 billion in 2020.

Teledermatology is a treatment procedure that is undertaken by using several communication technologies. It connects dermatologists and patients directly through a digital platform and enables medical professionals to provide effective solutions that help patients to recover faster. The rising cases of skin disorders among the aged population fuel teledermatology’s demand. It eliminates problems regarding waiting times and boosts treatment efficiency. For example, As per, the data published by Walk-in Dermatology Management, LLC, in August 2020, approximately 100,000 of the global population suffer from disorders while the number of dermatologists required to treat the patients is 3.3 dermatologists globally. Retailers, insurance companies, and pharmacies engage in partnership with several telehealth firms to increase awareness regarding the benefits of teleconsultations among the population.


Request a Sample Copy of the Research Report:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/teledermatology-market-103491


Rising Adoption of Telehealth and Artificial Intelligence (AI) Technologies to Boost Market Growth

Teledermatology is used extensively by several patients because of the rising awareness regarding its advantages. Increased healthcare expenditure and rising investments in healthcare services are expected to boost its demand drastically. For example, in 2017, as per the survey conducted by the National Business Group on Health, approximately 96% of employers and more than 500 employees were willing to provide insurance for telehealth facilities till 2019.

Further, the incorporation of artificial intelligence technologies is expected to boost the service’s effectiveness. AI and machine learning (ML) technologies help manufacturers to boost treatment efficiency by providing accurate data and pictures to enable medical professionals to cure patients more effectively. These factors are likely to fuel the teledermatology market growth. 


Click here to get the short-term and long-term impact of COVID-19 on this market.

Please visit: https://www.fortunebusinessinsights.com/teledermatology-market-103491


Presence of Major Companies to Boost Market Development in North America

North America is projected to dominate the teledermatology market share because of the presence of companies such as MDLive, DermatologistsOnCall, and others. Increasing adoption of telehealth services by insurance companies, health systems, physicians, and governments is expected to foster its adoption. These factors are likely to fuel market growth. 

In Europe, the early adoption of facilities is expected to increase its adoption. In addition, the presence of developed reimbursement policies is expected to fuel market progress. 

In Asia-Pacific, the rising adoption of these facilities in Australia, China, and Singapore is expected to propel industry growth. 


Quick Buy –  Teledermatology Market Research Report:

https://www.fortunebusinessinsights.com/checkout-page/103491


List of Key Players Profiled in the Market Report

  • 3Gen (U.S.)
  • Ksyos (Netherlands)
  • MetaOptima (Canada)
  • 3Derm(U.S.)
  • VigNet Inc. (U.S.)
  • Mple(Canada) 
  • MDLIVE Inc.(U.S.)
  • CureSkin(India)
  • Ping an Good Doctor (China)
  • FirstDerm (U.S.)


Have Any Query? Ask Our Experts:

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/teledermatology-market-103491


About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.


Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.